| NCT ID | NCT07091058 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Central Florida |
| Condition | Red Tide |
| Study Type | OBSERVATIONAL |
| Enrollment | 400 participants |
| Start Date | 2024-11-13 |
| Primary Completion | 2026-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 400 participants in total. It began in 2024-11-13 with a primary completion date of 2026-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to compare the frequency of symptoms, exposure and health impacts in persons living in areas where they are exposed to bloom and non-bloom periods of cyanobacteria and red tide in Florida.
Eligibility Criteria
Inclusion Criteria: * 18 years or older * live, visit, and/ or work in the following Florida counties: Indian River, St. Lucie, Charlotte, Collier, Hendry, Hillsborough, Lee, Manatee, Martin, Monroe, Okeechobee, Palm Beach, Pasco, Pinellas, Indian River, and/or Sarasota * able to read and understand English Exclusion Criteria: * unable to independently consent * younger than 18 years old * prisoner * pregnant women
Contact & Investigator
Rebecca Koszalinski, PhD, MS, RN, FIEL, CRRN, FARN
PRINCIPAL INVESTIGATOR
University of Central Florida
Frequently Asked Questions
Who can join the NCT07091058 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Red Tide. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07091058 currently recruiting?
Yes, NCT07091058 is actively recruiting participants. Contact the research team at Amoy.Fraser@ucf.edu for enrollment information.
Where is the NCT07091058 trial being conducted?
This trial is being conducted at Multiple Locations, United States.
Who is sponsoring the NCT07091058 clinical trial?
NCT07091058 is sponsored by University of Central Florida. The principal investigator is Rebecca Koszalinski, PhD, MS, RN, FIEL, CRRN, FARN at University of Central Florida. The trial plans to enroll 400 participants.